Pacira BioSciences, Inc. (PCRX) — Cash Flow-to-Debt Ratio
Pacira BioSciences, Inc. (PCRX) has a Cash Flow-to-Debt Ratio of 0.05x as of March 2026, meaning its operating cash flow of $25.68 Million could theoretically repay 0% of its total liabilities ($554.64 Million) in one year. See PCRX FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pacira BioSciences, Inc. Cash Flow-to-Debt Ratio (2008–2025)
Historical debt coverage capacity for Pacira BioSciences, Inc. across 18 annual periods. Also explore Pacira BioSciences, Inc. (PCRX) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Pacira BioSciences, Inc. (2008–2025)
Year-by-year debt coverage analysis for Pacira BioSciences, Inc.. For market capitalisation and broader financial context, see how much is Pacira BioSciences, Inc. worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.27x | $151.99 Million | $571.81 Million | ▲ +8.8% |
| 2024 | 0.24x | $189.39 Million | $775.17 Million | ▲ +11.3% |
| 2023 | 0.22x | $154.65 Million | $704.26 Million | ▲ +37.0% |
| 2022 | 0.16x | $145.27 Million | $906.19 Million | ▲ +71.5% |
| 2021 | 0.09x | $125.72 Million | $1.34 Billion | ▼ -20.5% |
| 2020 | 0.12x | $77.03 Million | $654.83 Million | ▼ -20.6% |
| 2019 | 0.15x | $70.52 Million | $476.12 Million | ▲ +11.6% |
| 2018 | 0.13x | $48.87 Million | $368.13 Million | ▲ +160.4% |
| 2017 | 0.05x | $17.79 Million | $348.89 Million | ▼ -73.7% |
| 2016 | 0.19x | $33.45 Million | $172.49 Million | ▲ +14.5% |
| 2015 | 0.17x | $29.00 Million | $171.23 Million | ▲ +3.0% |
| 2014 | 0.16x | $25.47 Million | $154.93 Million | ▲ +148.9% |
| 2013 | -0.34x | $-43.22 Million | $128.57 Million | ▲ +77.9% |
| 2012 | -1.52x | $-70.13 Million | $46.20 Million | ▼ -219.4% |
| 2011 | -0.48x | $-31.00 Million | $65.22 Million | ▼ -119.6% |
| 2010 | -0.22x | $-24.88 Million | $114.94 Million | ▲ +30.5% |
| 2009 | -0.31x | $-20.84 Million | $66.90 Million | ▲ +54.1% |
| 2008 | -0.68x | $-29.19 Million | $43.05 Million | — |